Delivery Order SPE2DB20D2104-SPE2DB22FS15H
- Not listed
- This federal contract award is a delivery order valued at $1,244.53, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vimpat 100 mg tablets, a medication used to treat epilepsy. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.55 firm fixed-price delivery order is for Vimpat 100 mg tablets, a medication used to treat epilepsy. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,777.80, is for the delivery of 60 tablets of Vimpat 100 mg, a pharmaceutical product. The award has a ceiling value of $2,777.80 and an ultimate completion date of December 29, 2023. This contract is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,274.41 firm fixed-price delivery order is for the supply of VIMPAT 100 mg tablets, a prescription medication used to treat epilepsy. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, valued at $2,980.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of Vimpat 100 mg tablets, a prescription medication used to treat epilepsy. This award...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,608.83, is for the delivery of Vimpat 150 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization. The contract does not have a set-aside designation,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of Vimpat 200 mg tablets, a medication used for the treatment of epilepsy. The contract has a total ceiling value of $21,808.80 and a period of performance through June 14, 2023. This award is not associated with a set-aside program, indicating open competition. Amerisourcebergen holds a larger...
- This federal contract award, valued at $1,229.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 150 mg tablets, a medication used to treat certain types of epilepsy. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific business category....
- This federal contract award, with ID SPE2DB20D3505|SPE2DB21FU4Q6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,251.44 firm fixed-price delivery order is for the pharmaceutical product Vimpat (200 mg tablets, 60 count). This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,746.97, is for the supply of 60 tablets of Vimpat 200 mg, a medication used to treat epilepsy. The contract has an ultimate completion date of May 2, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. The award is part of a larger Indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS15HDelivery Order
This federal contract award, with a ceiling value of $1,021.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of Vimpat 200 mg tablets, a medication used for the treatment of epilepsy. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating that it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/22/22 |